BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29217686)

  • 1. Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.
    Perez-Villalba A; Sirerol-Piquer MS; Belenguer G; Soriano-Cantón R; Muñoz-Manchado AB; Villadiego J; Alarcón-Arís D; Soria FN; Dehay B; Bezard E; Vila M; Bortolozzi A; Toledo-Aral JJ; Pérez-Sánchez F; Fariñas I
    J Neurosci; 2018 Jan; 38(4):814-825. PubMed ID: 29217686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent Cyfip1 Expression Is Required to Maintain the Adult Subventricular Zone Neurogenic Niche.
    Habela CW; Yoon KJ; Kim NS; Taga A; Bell K; Bergles DE; Maragakis NJ; Ming GL; Song H
    J Neurosci; 2020 Mar; 40(10):2015-2024. PubMed ID: 31988061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
    Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
    Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
    Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
    J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein.
    Schlachetzki JC; Grimm T; Schlachetzki Z; Ben Abdallah NM; Ettle B; Vöhringer P; Ferger B; Winner B; Nuber S; Winkler J
    J Neurosci Res; 2016 Jan; 94(1):62-73. PubMed ID: 26451750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
    Pavia-Collado R; Rodríguez-Aller R; Alarcón-Arís D; Miquel-Rio L; Ruiz-Bronchal E; Paz V; Campa L; Galofré M; Sgambato V; Bortolozzi A
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.
    Zaltieri M; Grigoletto J; Longhena F; Navarria L; Favero G; Castrezzati S; Colivicchi MA; Della Corte L; Rezzani R; Pizzi M; Benfenati F; Spillantini MG; Missale C; Spano P; Bellucci A
    J Cell Sci; 2015 Jul; 128(13):2231-43. PubMed ID: 25967550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype.
    Faustini G; Longhena F; Masato A; Bassareo V; Frau R; Klingstedt T; Shirani H; Brembati V; Parrella E; Vezzoli M; Nilsson KPR; Pizzi M; Spillantini MG; Bubacco L; Bellucci A
    Mol Ther; 2022 Apr; 30(4):1465-1483. PubMed ID: 35038583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-dependent anion channel involved in the α-synuclein-induced dopaminergic neuron toxicity in rats.
    Lu L; Zhang C; Cai Q; Lu Q; Duan C; Zhu Y; Yang H
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):170-8. PubMed ID: 23291291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.
    Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host Microenvironment.
    Zuo FX; Bao XJ; Sun XC; Wu J; Bai QR; Chen G; Li XY; Zhou QY; Yang YF; Shen Q; Wang RZ
    Int J Mol Sci; 2015 Nov; 16(11):26473-92. PubMed ID: 26556344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Neural Progenitor Transplantation Rescues Behavior and Reduces α-Synuclein in a Transgenic Model of Dementia with Lewy Bodies.
    Goldberg NRS; Marsh SE; Ochaba J; Shelley BC; Davtyan H; Thompson LM; Steffan JS; Svendsen CN; Blurton-Jones M
    Stem Cells Transl Med; 2017 Jun; 6(6):1477-1490. PubMed ID: 28225193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 Enhances Subventricular Zone Neurogenesis by Inhibiting NLRP3/Caspase-1 Axis in Adult Neural Stem Cells.
    Fan Z; Lu M; Qiao C; Zhou Y; Ding JH; Hu G
    Mol Neurobiol; 2016 Dec; 53(10):7057-7069. PubMed ID: 26676570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.